ArticleOncoTargets and therapy2021

A c-Met Inhibitor Suppresses Osteosarcoma Progression via the ERK1/2 Pathway in Human Osteosarcoma Cells.

Weijie Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.